- Wound Management
- Burn Surgery
- Reconstructive Surgery
Learn More About How MatriDerm Positively Impacts Hospital Operations
3 Key Reasons More Health Systems are Choosing MatriDerm
Patient Treatment Time
MatriDerm becomes vascularized in 3-7 days versus the competition that takes 21-28 days which significantly reduces time to closure1,2,3
Decreased Risk of Infection
MatriDerm shows <5% infection rate in reported literature versus 14-55% for the market leading competitor. Surgical Site Infections lead to increased costs and poor patient care.7,8,9
Cost Effectiveness
MatriDerm’s standard one-time application protocol represents improved efficiency and cost reduction versus wound care products which are reapplied every 7-14 days. Additionally, MatriDerm is often reported to provide an upfront material cost savings versus other dermal matrices.
Backed by 20+ Years of Clinical Evidence
With more than 200 publications, 5 RCTs and a 12-year follow-up study, MatriDerm is backed by proven evidence. Explore MatriDerm’s publications and resource library to learn more.
Value Analysis & Contract Approval Support
The MatriDerm team understands the importance of evaluating new treatment options and the importance of bringing those options to surgeons and their patients as efficiently as possible. If your organization is currently reviewing MatriDerm, we have resources that can help.
Connect with a MatriDerm team member to learn more or request value analysis support.
Explore the Latest News and Resources
Revolutionizing Soft Tissue Reconstruction: How MatriDerm® is Overcoming the Status Quo
Employee Spotlight: Josh Shuryan, Strategic Market Development Manager
Revolutionizing Soft Tissue Reconstruction: How MatriDerm® is Overcoming the Status Quo